Alterity Therapeutics (ATHE) Exchange Rate Effect (2016 - 2020)
Alterity Therapeutics (ATHE) recorded quarterly Exchange Rate Effect of -$172360.6 in Q2 2020, down 297.37% quarter-over-quarter from $87328.6 in Q4 2019, and up 39.07% on a YoY basis from -$123933.5 in Q3 2019.
Alterity Therapeutics (ATHE) Exchange Rate Effect (2016 - 2020) Analysis & Trends
Alterity Therapeutics' Exchange Rate Effect history runs 5 years deep, the most recent figure standing at -$172360.6 for Q2 2020.
- In Q2 2020, Exchange Rate Effect rose 39.07% year-over-year to -$172360.6; the TTM figure through Jun 2020 stood at -$203082.4 (up 65.29% YoY), while the FY2025 annual figure was -$127045.9, down 174.04% from the prior year.
- Exchange Rate Effect was -$172360.6 for Q2 2020 at Alterity Therapeutics, down from $87328.6 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $409359.2 in Q4 2016 to a low of -$709904.9 in Q2 2016.
- Historically, Exchange Rate Effect has averaged -$121323.2 across 5 years, with a median of -$85127.6 in 2018.
- The sharpest annual moves came in 2018 and 2019: Exchange Rate Effect surged 135.15% in 2018, then plunged 13536.85% in 2019.
- A 5-year view of Exchange Rate Effect shows it stood at $409359.2 in 2016, then sank by 214.58% to -$469062.8 in 2017, then soared by 135.15% to $164855.6 in 2018, then plunged by 47.03% to $87328.6 in 2019, then slumped by 297.37% to -$172360.6 in 2020.
- The last three Exchange Rate Effect figures came in at -$172360.6 (Q2 2020), $87328.6 (Q4 2019), and -$282906.0 (Q2 2019), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -900,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | -172,360.55 |
| Jun 30, 2020 | -172,360.55 |
| Dec 31, 2019 | 87,328.62 |
| Dec 31, 2019 | 87,328.62 |
| Jun 30, 2019 | -282,906.04 |
| Jun 30, 2019 | -282,906.04 |
| Dec 31, 2018 | 164,855.57 |
| Dec 31, 2018 | 164,855.57 |
| Jun 30, 2018 | 2,105.45 |
| Jun 30, 2018 | 2,105.45 |
| Dec 31, 2017 | -469,062.76 |
| Dec 31, 2017 | -469,062.76 |
| Dec 31, 2016 | 409,359.19 |
| Dec 31, 2016 | 409,359.19 |
| Jun 30, 2016 | -709,904.92 |
| Jun 30, 2016 | -709,904.92 |